null
ChEBI ID: 46918
| Member | Definition | Role |
|---|---|---|
| 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine; 5-(2-methylpiperazine-1-sulfonyl)isoquinoline | |
| 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group. | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine; 5-(2-methylpiperazine-1-sulfonyl)isoquinoline |
| 1,4-bis(thiophen-2-ylsulfonyl)piperazine | 1,4-bis(thiophen-2-ylsulfonyl)piperazine | |
| vardenafil | The sulfonamide resulting from formal condensation of the sulfo group of 4-ethoxy-3-(5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one-2-yl)benzenesulfonic acid and the secondary amino group of 4-ethylpiperazine. | vardenafil |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 279 (8.33) | 18.7374 |
| 1990's | 1,666 (49.73) | 18.2507 |
| 2000's | 684 (20.42) | 29.6817 |
| 2010's | 634 (18.93) | 24.3611 |
| 2020's | 87 (2.60) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 41 (1.19%) | 5.53% |
| Reviews | 85 (2.46%) | 6.00% |
| Case Studies | 10 (0.29%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 3,317 (96.06%) | 84.16% |